Physician profile
William Bentley
NPI 1295053171
$11,534.15
in general payments reported to CMS, 2019-2025
25 companies · $3,374 in 2025
The $3,374 reported for 2025 was more than what 98% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $366 · 2020: $242 · 2021: $922 · 2022: $947 · 2023: $2,194 · 2024: $3,490 · 2025: $3,374.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $4,635 · Food and Beverage: $4,390 · Entertainment: $33.26.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $4,635.10 |
| Food and Beverage | $4,389.59 |
| Entertainment | $33.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Saluda Medical Americas, INC. | $4,948.73 | 2024-2025 | Evoke |
| Medtronic, INC. | $1,390.31 | 2021-2025 | Intellis Adaptivestim, Adaptix Interbody System With Titan Nanolock Surface Technology, Mazor X System |
| Relievant Medsystems, INC. | $1,327.72 | 2023 | Intracept |
| Abbott Laboratories | $844.17 | 2019-2025 | Proclaim, Octrode, Swift-Lock |
| Nevro Corp. | $721.16 | 2019-2024 | Senza |
| Boston Scientific Corporation | $631.41 | 2019-2025 | Intracept, Intracept Rf Probe, General - Pain Management |
| Vertos Medical, INC. | $543.20 | 2023-2024 | Mild Device Kit |
| Globus Medical, INC. | $232.17 | 2025 | Senza |
| Si-Bone, INC. | $175.25 | 2019-2022 | |
| Pacira Therapeutics, INC. | $146.80 | 2019-2021 | |
| Stryker Corporation | $125.37 | 2024-2025 | Mild Device Kit |
| Foundation Fusion Solutions, LLC | $121.15 | 2021-2025 | |
| Scilex Pharmaceuticals INC. | $82.82 | 2022-2024 | Ztlido |
| Spr Therapeutics, INC | $35.82 | 2024-2025 | Sprint Pns System |
| Collegium Pharmaceutical, INC. | $32.41 | 2019-2025 | Xtampza |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $29.32 | 2019-2020 | |
| Avanos Medical | $21.27 | 2025 | Generator |
| Averitas Pharma INC. | $19.46 | 2025 | Qutenza |
| Biodelivery Sciences International, INC. | $16.78 | 2021 | |
| Abbvie INC. | $16.27 | 2023 | Botox |
| Vertex Pharmaceuticals Incorporated | $15.84 | 2025 | |
| Pfizer INC. | $14.57 | 2019 | |
| Allergan, INC. | $14.28 | 2019 | |
| Medtronic USA, INC. | $14.07 | 2019 | |
| Biotronik Nro, INC. | $13.80 | 2025 | Prospera |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Bentley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.